Skip to main content
. 2020 Feb 25;11(4):899–908. doi: 10.1002/jcsm.12553

Figure 2.

Figure 2

Fasting blood glucose (A), serum S100A9 (B), and serum galectin‐3 (C) levels in patients with pancreatic cancer‐associated diabetes.